TrialBritish journal of haematology2014

SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia.

Anjali S Advani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.